146 related articles for article (PubMed ID: 10207502)
21. Growth hormone, IGF-I, and the elderly. Clues to potential therapeutic interventions.
Rosen CJ
Endocrine; 1997 Aug; 7(1):39-40. PubMed ID: 9449029
[No Abstract] [Full Text] [Related]
22. Off-label use of recombinant igf-I to promote growth: is it appropriate?
Rosenbloom AL; Rivkees SA
J Clin Endocrinol Metab; 2010 Feb; 95(2):505-8. PubMed ID: 20133470
[No Abstract] [Full Text] [Related]
23. Changes in endothelial dysfunction and associated cardiovascular disease morbidity markers in GH-IGF axis pathology.
Graham MR; Evans P; Thomas NE; Davies B; Baker JS
Am J Cardiovasc Drugs; 2009; 9(6):371-81. PubMed ID: 19929035
[TBL] [Abstract][Full Text] [Related]
24. Determinants of Frailty and Longevity: Are They the Same Ones?
Rodríguez Mañas L
Nestle Nutr Inst Workshop Ser; 2015; 83():29-39. PubMed ID: 26485702
[TBL] [Abstract][Full Text] [Related]
25. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
Ranke MB; Wollmann HA; Savage MO
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
[No Abstract] [Full Text] [Related]
26. Physiological effects and potential applications of GH and IGF-I.
Fryburg DA; Barrett EJ
Diabetes Nutr Metab; 1999 Oct; 12(5):329-36. PubMed ID: 10741347
[No Abstract] [Full Text] [Related]
27. Osteoporosis and the growth hormone-insulin-like growth factor axis.
Geusens PP; Boonen S
Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
[TBL] [Abstract][Full Text] [Related]
28. Somatopause: state of the art.
Di Somma C; Brunelli V; Savanelli MC; Scarano E; Savastano S; Lombardi G; Colao A
Minerva Endocrinol; 2011 Sep; 36(3):243-55. PubMed ID: 22019753
[TBL] [Abstract][Full Text] [Related]
29. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span.
Thorner MO
J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1039-44. PubMed ID: 19587105
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
[TBL] [Abstract][Full Text] [Related]
31. The aging population--is there a role for endocrine interventions?
Nass R; Johannsson G; Christiansen JS; Kopchick JJ; Thorner MO
Growth Horm IGF Res; 2009 Apr; 19(2):89-100. PubMed ID: 18977675
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrinology of the human growth hormone-insulin-like growth factor I axis during ageing.
Arvat E; Giordano R; Gianotti L; Broglio F; Camanni F; Ghigo E
Growth Horm IGF Res; 1999 Apr; 9 Suppl A():111-5. PubMed ID: 10429893
[No Abstract] [Full Text] [Related]
33. [Growth hormone and the aging process].
Yaretzky A; Vigder C
Harefuah; 1998 Apr; 134(8):641-5. PubMed ID: 10911432
[No Abstract] [Full Text] [Related]
34. [Somatopause: the present state-of-art].
Krysiak R; Kedzia A; Okopień B
Wiad Lek; 2009; 62(1):52-61. PubMed ID: 19817258
[TBL] [Abstract][Full Text] [Related]
35. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
Devin JK; Young PP
Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
[TBL] [Abstract][Full Text] [Related]
36. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
37. [Senile osteoporosis].
Sugimoto T
Nihon Rinsho; 2005 Oct; 63 Suppl 10():566-71. PubMed ID: 16279702
[No Abstract] [Full Text] [Related]
38. [Hormones and osteoporosis update. Growth hormone and bone].
Tanaka H
Clin Calcium; 2009 Jul; 19(7):984-9. PubMed ID: 19567995
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-Sponsored Symposium.
Rosen CJ; Conover C
J Clin Endocrinol Metab; 1997 Dec; 82(12):3919-22. PubMed ID: 9398687
[No Abstract] [Full Text] [Related]
40. Frailty, disability and physical exercise in the aging process and in chronic kidney disease.
Greco A; Paroni G; Seripa D; Addante F; Dagostino MP; Aucella F
Kidney Blood Press Res; 2014; 39(2-3):164-8. PubMed ID: 25117919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
